Laurie Lisak

830 total citations
15 papers, 625 citations indexed

About

Laurie Lisak is a scholar working on Hematology, Molecular Biology and Orthopedics and Sports Medicine. According to data from OpenAlex, Laurie Lisak has authored 15 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 6 papers in Molecular Biology and 4 papers in Orthopedics and Sports Medicine. Recurrent topics in Laurie Lisak's work include Acute Myeloid Leukemia Research (15 papers), Retinoids in leukemia and cellular processes (5 papers) and Bone and Joint Diseases (4 papers). Laurie Lisak is often cited by papers focused on Acute Myeloid Leukemia Research (15 papers), Retinoids in leukemia and cellular processes (5 papers) and Bone and Joint Diseases (4 papers). Laurie Lisak collaborates with scholars based in United States and Germany. Laurie Lisak's co-authors include Azra Raza, Sefer Gezer, Parameswaran Venugopal, Saleem Dar, Francesca Zorat, Fabiana Nascimben, Jerome Loew, Peter Meyer, Jerome B. Zeldis and Vilasini Shetty and has published in prestigious journals such as Blood, British Journal of Haematology and Experimental Hematology.

In The Last Decade

Laurie Lisak

15 papers receiving 603 citations

Peers

Countries citing papers authored by Laurie Lisak

Since Specialization

Citations

This map shows the geographic impact of Laurie Lisak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurie Lisak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurie Lisak more than expected).

Fields of papers citing papers by Laurie Lisak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurie Lisak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurie Lisak. The network helps show where Laurie Lisak may publish in the future.

Co-authorship network of co-authors of Laurie Lisak

This figure shows the co-authorship network connecting the top 25 collaborators of Laurie Lisak. A scholar is included among the top collaborators of Laurie Lisak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurie Lisak. Laurie Lisak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Phase II study of topotecan and thalidomide in patients with high-risk myelodysplastic syndromes 2006 ·Leukemia & lymphoma ·Azra Raza, Laurie Lisak, (unknown), (unknown), Muhammad Ali Mumtaz, (unknown), (unknown), Naomi Galili	13
2	Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high pre-therapy EVI1 expression 2004 ·Leukemia Research ·Azra Raza, Silvia Buonamici, Laurie Lisak, (unknown), Donglan Li, (unknown), (unknown), (unknown), (unknown), (unknown), Muhammad Ali Mumtaz, Sefer Gezer, Parameswaran Venugopal, Poluru L. Reddy, Naomi Galili, Anna Candoni, Jack W. Singer, Giuseppina Nucifora	59
3	Remicade as TNF Suppressor in Patients with Myelodysplastic Syndromes 2004 ·Leukemia & lymphoma ·Azra Raza, Anna Candoni, Uzair Ali Khan, Laurie Lisak, (unknown), F Silvestri, (unknown), (unknown), Muhammad Ali Mumtaz, Sefer Gezer, Parameswaran Venugopal, (unknown), Naomi Galili	44
4	Arsenic Trioxide (Trisenox®) with/without Thalidomide in Patients with Myelodysplastic Syndromes (MDS) Produces Hematologic Improvement (HI). 2004 ·Blood ·Azra Raza, Laurie Lisak, (unknown), (unknown), (unknown), (unknown), Poluru L. Reddy, Naomi Galili	1
5	Involvement of Cyclin D1 and E2F1 in Intramedullary Apoptosis in Myelodysplastic Syndromes 2003 ·Journal of Hematotherapy & Stem Cell Research ·Gurveen Saberwal, (unknown), İmke Janssen, Vilasini Shetty, Sairah Alvi, Laurie Lisak, Parameswaran Venugopal, Azra Raza, Suneel Mundle	11
6	Successful establishment of long-term bone marrow cultures in 103 patients with myelodysplastic syndromes 2001 ·Leukemia Research ·Sairah Alvi, (unknown), Vilasini Shetty, (unknown), (unknown), Francesca Zorat, (unknown), Shalini Anthwal, Laurie Lisak, (unknown), Sefer Gezer, Suneel Mundle, Poluru L. Reddy, Krishnan Allampallam, Xiaoke Huang, Naomi Galili, Raphael Borok, (unknown)	24
7	The clinical and biological effects of thalidomide in patients with myelodysplastic syndromes 2001 ·British Journal of Haematology ·Francesca Zorat, Vilasini Shetty, (unknown), Laurie Lisak, Fabiana Nascimben, Krishnan Allampallam, Saleem Dar, (unknown), Sefer Gezer, Parameswaran Venugopal, Azra Raza	85
8	Thalidomide produces transfusion independence in long-standing refractory anemias of patients with myelodysplastic syndromes 2001 ·Blood ·Azra Raza, Peter Meyer, (unknown), Francesca Zorat, Laurie Lisak, Fabiana Nascimben, (unknown), (unknown), (unknown), Jerome Loew, Saleem Dar, Sefer Gezer, Parameswaran Venugopal, Jerome B. Zeldis	239
9	Novel in Vitro Culture and Ultrastructural Techniques to Study the Biology of Myelodysplastic Syndromes (MDS) 2001 ·Cancer treatment and research ·Sairah Alvi, Laurie Lisak, Vilasini Shetty	2
10	The Clinical and Biologic Significance of Abnormal Lipid Profiles in Patients with Myelodysplastic Syndromes 2000 ·Journal of Hematotherapy & Stem Cell Research ·(unknown), (unknown), (unknown), V. Shetty, Suneel Mundle, Laurie Lisak, (unknown), Bilal Ahmed, Luigi Mazzone, Francesca Zorat, Raphael Borok, (unknown), Aijaz Gundroo, (unknown), (unknown)	34
11	Patients with myelodysplastic syndromes benefit from palliative therapy with amifostine, pentoxifylline, and ciprofloxacin with or without dexamethasone 2000 ·Blood ·Azra Raza, (unknown), Laurie Lisak, (unknown), Saleem Dar, (unknown), (unknown), Sefer Gezer, Stephanie Gregory, Jerome Loew, Erwin Robin, (unknown), (unknown), Raywin Huang	59
12	Improvement in cytopenias of patients with myelodysplastic syndromes (Mds) In response to thalidomide 2000 ·Experimental Hematology ·Azra Raza, Laurie Lisak, (unknown), (unknown), (unknown), (unknown), Parameswaran Venugopal	4
13	Pentoxifylline, Ciprofloxacin and Dexamethasone Improve the Ineffective Hematopoiesis in Myelodysplastic Syndrome Patients 2000 ·Hematology ·Azra Raza, (unknown), (unknown), Saleem Dar, Laurie Lisak, Raywin Huang, Parameswaran Venugopal, Sefer Gezer, Stephanie A. Gregory, (unknown), Jerome Loew, Erwin Robin, (unknown), (unknown), (unknown), Robert L. Taylor, (unknown)	14
14	Biologic Characteristics of 164 Patients with Myelodysplastic Syndromes 1999 ·Leukemia & lymphoma ·(unknown), Saleem Dar, (unknown), (unknown), Suneel Mundle, Vilasini Shetty, Parameswaran Venugopal, Irfan Ali, Laurie Lisak, Azra Raza	18
15	Biologic characteristics of patients with hypocellular myelodysplastic syndromes 1999 ·Leukemia Research ·Rajat Goyal, (unknown), Irfan Ali, Saleem Dar, Suneel Mundle, (unknown), (unknown), Krishnan Allampallam, Laurie Lisak, Jerome Loew, Parameswaran Venugopal, Sefer Gezer, Erwin Robin, (unknown), Azra Raza	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact